CMV colitis

Revision as of 00:04, 26 February 2017 by ClaireLewis (talk | contribs) (Clinical Features)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References